GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » EBITDA Margin %

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) EBITDA Margin % : 0.00% (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CTT Pharmaceutical Holdings's EBITDA for the three months ended in Jun. 2018 was $-1.09 Mil. CTT Pharmaceutical Holdings's Revenue for the three months ended in Jun. 2018 was $0.00 Mil. Therefore, CTT Pharmaceutical Holdings's EBITDA margin for the quarter that ended in Jun. 2018 was 0.00%.


CTT Pharmaceutical Holdings EBITDA Margin % Historical Data

The historical data trend for CTT Pharmaceutical Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings EBITDA Margin % Chart

CTT Pharmaceutical Holdings Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CTT Pharmaceutical Holdings Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Mar17 Jun17 Mar18 Jun18
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -70.00 - - -

Competitive Comparison of CTT Pharmaceutical Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTT Pharmaceutical Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's EBITDA Margin % falls into.



CTT Pharmaceutical Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CTT Pharmaceutical Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2015 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=-1.446/0
= %

CTT Pharmaceutical Holdings's EBITDA Margin % for the quarter that ended in Jun. 2018 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2018 )/Revenue (Q: Jun. 2018 )
=-1.09/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTT Pharmaceutical Holdings  (OTCPK:CTTH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


CTT Pharmaceutical Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
Executives
Albert C Zapanta director PO BOX 2020, SPRINGDALE AR 72765
William Thomson director 390 BAY ST, SUITE 1102, TORONTO ONTARIO A6 M5H 2Y2